We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Neurocognitive battery possible in 3-year-olds throughout leukemia remedy
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Neurocognitive battery possible in 3-year-olds throughout leukemia remedy
Neurocognitive battery possible in 3-year-olds throughout leukemia remedy
Health

Neurocognitive battery possible in 3-year-olds throughout leukemia remedy

Last updated: December 19, 2024 3:44 am
Editorial Board Published December 19, 2024
Share
SHARE

A short neurocognitive battery is possible to be used in 3-year-olds throughout acute lymphoblastic leukemia remedy, in line with a research printed on-line Dec. 9 in Pediatric Blood & Most cancers.

Sameera Ramjan, from Memorial Sloan Kettering Most cancers Heart in New York Metropolis, and colleagues provided sufferers enrolled within the Remedy of Newly Identified Acute Lymphoblastic Leukemia in Youngsters and Adolescents participation in an non-compulsory neurocognitive research assessing longitudinal modifications in neurocognitive perform. The evaluation included 3- and 4-year-old sufferers enrolled within the research.

The researchers discovered that 3-year-old sufferers didn’t differ from 4-year-olds by way of their potential to carry out or full the temporary Cogstate battery assessing psychomotor perform (detection) and a spotlight (identification). These findings endured at 4 time-point assessments, by means of 52 weeks after prognosis.

“This report demonstrates that computerized testing, such as Cogstate, can be successfully administered to 3-year-old patients who are undergoing treatment for acute lymphoblastic leukemia, thereby capturing serial test data on a vulnerable patient population that, in prior studies, have demonstrated worse neurocognitive deficits,” the authors write.

“Consequently, changing future study inclusion criteria to include patients diagnosed at the age of 3 years will ultimately serve to improve our understanding of at-risk patients and the neurocognitive trajectory of this age group both during treatment as well as into survivorship, thereby leading to the development of early interventions.”

One creator disclosed ties to the pharmaceutical trade; two authors disclosed ties to Cogstate.

Extra data:
Sameera Ramjan et al, Feasibility of Using a Transient Neurocognitive Battery in 3‐Yr‐Previous Sufferers Throughout Remedy for Acute Lymphoblastic Leukemia, Pediatric Blood & Most cancers (2024). DOI: 10.1002/pbc.31469

Quotation:
Neurocognitive battery possible in 3-year-olds throughout leukemia remedy (2024, December 18)
retrieved 18 December 2024
from https://medicalxpress.com/information/2024-12-neurocognitive-battery-feasible-year-olds.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

Blood vessels and immune cells that defend the mind additionally drive threat for Alzheimer’s and stroke

Decide up the tempo of your each day stroll to spice up longevity, specialists say

To remain sharper whereas ageing, get energetic, problem your mind, and eat wholesome

Most liver most cancers circumstances are because of preventable threat elements, evaluation suggests

Examine provides clearer image of childhood mind tumor survival

TAGGED:3yearoldsbatteryfeasibleLeukemiaNeurocognitivetreatment
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Excessive charges of opioid use present in NZ pregnancies
Health

Excessive charges of opioid use present in NZ pregnancies

Editorial Board May 26, 2025
The Silent Weight of Privilege: Depression, Anhedonia, and the Psychoneuroimmunology of the 1%
Mets Pocket book: Francisco Lindor day-to-day with damaged toe
Adams aide Winnie Greco, ensnared in a federal probe, met usually with Chinese language authorities operatives
How Sanctions on Russia Could Affect Champions League and Top Soccer Clubs

You Might Also Like

Providing self-collection kits at GP appointments may forestall 1,000 girls a 12 months from growing cervical most cancers
Health

Providing self-collection kits at GP appointments may forestall 1,000 girls a 12 months from growing cervical most cancers

July 29, 2025
Vagus nerve stimulation may assist individuals get extra train
Health

Vagus nerve stimulation may assist individuals get extra train

July 28, 2025
Examine finds economically deprived sufferers at larger danger for lengthy COVID
Health

Examine finds economically deprived sufferers at larger danger for lengthy COVID

July 28, 2025
Scientists pinpoint hazards for engineered stone fabrication store staff
Health

Scientists pinpoint hazards for engineered stone fabrication store staff

July 28, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?